KitoTech Medical
Ron Berenson, MD, is a serial entrepreneur, who has founded and served as CEO of several biomedical ventures (CellPro, Xcyte, HemaQuest, Fe3, Aequus), including two NASDAQ-listed companies. He has 30 years of experience in fundraising, business development, product development, clinical & regulatory affairs, and commercialization of medical products, including skin devices. He is a graduate of Stanford University and Yale Medical School and a former faculty member at the University of Washington.
This person is not in any offices
KitoTech Medical
KitoTech Medical is a Seattle-based medical device company that has developed microMend, a unique wound closure device.